Prospera Financial Services’s Regenxbio RGNX Stock Holding History

Prospera Financial Services’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200	Closed	-$7K	–	2381
2022 Q1	$7K	Buy	+200	New	+$5.56K	﹤0.01%	2175

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Prospera Financial Services's RGNX Position: Q2 2022 in Review

Prospera Financial Services sold out of Regenxbio (RGNX) in Q2 2022, closing a stake of 200 shares — an estimated $7K sold.

Prospera Financial Services first reported a position in RGNX in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.

Prospera Financial Services reported no remaining Regenxbio position as of Q2 2022 after selling out during the quarter.
Prospera Financial Services sold 200 Regenxbio shares in Q2 2022, an estimated $7K.
Prospera Financial Services first reported a position in Regenxbio in Q1 2022 and held it in 1 quarter.
Prospera Financial Services's Regenxbio position peaked at $7K in Q1 2022.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.